Skip to main content
Caplight Logo









Hangzhou Artery Technology Co., Ltd.

Hangzhou Artery Technology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://www.arterytech.com/

Last Round

IPO

Jan 29, 2026

Company Overview

Hangzhou Artery Technology Co., Ltd. is a medical technology company that specializes in high-performance computing for medical imaging and AI-driven diagnostic solutions for cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

fractional flow reserveFFR-CTcomputational fluid dynamicsCFDcardiovascular diagnosticsmedical imaging softwareplaque risk predictionsurgical planning softwaremedical AIcoronary artery diseasenon-invasive diagnosticsAI-powered radiologyvirtual stentingdigital twin heartclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Artery Technology Co., Ltd. Comparables

Compare Hangzhou Artery Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Artery Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Raysight Medical
87%
Shukun Technology
86%
Shanghai United Imaging Healthcare
84%

Hangzhou Artery Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJan 29, 2026

Hangzhou Artery Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou Artery Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hangzhou Artery Technology Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou Artery Technology Co., Ltd. a public or private company?

Hangzhou Artery Technology Co., Ltd. is a private company.

What is the current stock price of Hangzhou Artery Technology Co., Ltd.?

Hangzhou Artery Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Hangzhou Artery Technology Co., Ltd. worth (valuation)?

Valuation information for Hangzhou Artery Technology Co., Ltd. is not publicly available.

Can I buy Hangzhou Artery Technology Co., Ltd. stock?

Hangzhou Artery Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hangzhou Artery Technology Co., Ltd.'s last funding round?

Hangzhou Artery Technology Co., Ltd.'s most recent funding round was IPO on January 29, 2026.

Who are the main investors in Hangzhou Artery Technology Co., Ltd.?

Investor information for Hangzhou Artery Technology Co., Ltd. is not publicly disclosed.

Will Hangzhou Artery Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou Artery Technology Co., Ltd..

How can I track Hangzhou Artery Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Artery Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Year Founded2018
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?